Literature DB >> 21945473

Progesterone regulation of stem and progenitor cells in normal and malignant breast.

Sunshine Daddario Axlund1, Carol A Sartorius.   

Abstract

Progesterone plays an important, if not controversial, role in mammary epithelial cell proliferation and differentiation. Evidence supports that progesterone promotes rodent mammary carcinogenesis under some conditions, progesterone receptors (PR) are necessary for murine mammary gland tumorigenesis, and exogenous progestin use in post-menopausal women increases breast cancer risk. Thus, the progesterone/PR signaling axis can promote mammary tumorigenesis, albeit in a context-dependent manner. A mechanistic basis for the tumor promoting actions of progesterone has thus far remained unknown. Recent studies, however, have identified a novel role for progesterone in controlling the number and function of stem and progenitor cell populations in the normal human and mouse mammary glands, and in human breast cancers. These discoveries promise to reshape our perception of progesterone function in the mammary gland, and have spawned new hypotheses for how progestins may increase the risk of breast cancer. Here we review studies on progesterone regulation of mammary stem cells in normal and malignant tissue, and their implications for breast cancer risk, tumorigenesis, and tumor behavior.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21945473      PMCID: PMC3288619          DOI: 10.1016/j.mce.2011.09.021

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  86 in total

1.  Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor alpha, epidermal growth factor receptor, c-fos, and c-myc genes.

Authors:  E A Musgrove; C S Lee; R L Sutherland
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

Review 2.  Hormonal prevention of hereditary breast cancer.

Authors:  S A Narod
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

3.  Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer.

Authors:  Daniel Schramek; Andreas Leibbrandt; Verena Sigl; Lukas Kenner; John A Pospisilik; Heather J Lee; Reiko Hanada; Purna A Joshi; Antonios Aliprantis; Laurie Glimcher; Manolis Pasparakis; Rama Khokha; Christopher J Ormandy; Martin Widschwendter; Georg Schett; Josef M Penninger
Journal:  Nature       Date:  2010-09-29       Impact factor: 49.962

4.  Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth.

Authors:  Carol A Sartorius; Djuana M E Harvell; Tianjie Shen; Kathryn B Horwitz
Journal:  Cancer Res       Date:  2005-11-01       Impact factor: 12.701

5.  Steroid hormone receptor status of mouse mammary stem cells.

Authors:  Marie-Liesse Asselin-Labat; Mark Shackleton; John Stingl; François Vaillant; Natasha C Forrest; Connie J Eaves; Jane E Visvader; Geoffrey J Lindeman
Journal:  J Natl Cancer Inst       Date:  2006-07-19       Impact factor: 13.506

Review 6.  Epidemiology of endocrine-related risk factors for breast cancer.

Authors:  Leslie Bernstein
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-01       Impact factor: 2.673

7.  Amphiregulin mediates estrogen, progesterone, and EGFR signaling in the normal rat mammary gland and in hormone-dependent rat mammary cancers.

Authors:  Anastasia Kariagina; Jianwei Xie; Jeffrey R Leipprandt; Sandra Z Haslam
Journal:  Horm Cancer       Date:  2010-11-23       Impact factor: 3.869

8.  Regulation of progesterone receptor signaling by BRCA1 in mammary cancer.

Authors:  Pragati Katiyar; Yongxian Ma; Saijun Fan; Richard G Pestell; Priscilla A Furth; Eliot M Rosen
Journal:  Nucl Recept Signal       Date:  2006-04-28

9.  Keratin 6 is not essential for mammary gland development.

Authors:  Sandra L Grimm; Wen Bu; Mary Ann Longley; Dennis R Roop; Yi Li; Jeffrey M Rosen
Journal:  Breast Cancer Res       Date:  2006-06-21       Impact factor: 6.466

10.  Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells.

Authors:  Gabriela Dontu; Kyle W Jackson; Erin McNicholas; Mari J Kawamura; Wissam M Abdallah; Max S Wicha
Journal:  Breast Cancer Res       Date:  2004-08-16       Impact factor: 6.466

View more
  22 in total

1.  Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.

Authors:  Peter Kabos; Jessica Finlay-Schultz; Chunling Li; Enos Kline; Christina Finlayson; Joshua Wisell; Christopher A Manuel; Susan M Edgerton; J Chuck Harrell; Anthony Elias; Carol A Sartorius
Journal:  Breast Cancer Res Treat       Date:  2012-07-24       Impact factor: 4.872

2.  Evaluation of BrightGen HR RT-qDx assay to detect nuclear receptors mRNA overexpression in FFPE breast cancer tissue samples for selection of tamoxifen therapy.

Authors:  Hye-Young Wang; Sangjung Park; Sunghyun Kim; Sungwoo Ahn; Dongsup Lee; Seungil Kim; Dongju Jung; Kwang Hwa Park; Hyeyoung Lee
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 3.  Wip1 phosphatase in breast cancer.

Authors:  A Emelyanov; D V Bulavin
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

Review 4.  Progesterone and Breast Cancer.

Authors:  Britton Trabert; Mark E Sherman; Nagarajan Kannan; Frank Z Stanczyk
Journal:  Endocr Rev       Date:  2020-04-01       Impact factor: 19.871

5.  A high-content assay to identify small-molecule modulators of a cancer stem cell population in luminal breast cancer.

Authors:  Byong Hoon Yoo; Sunshine Daddario Axlund; Peter Kabos; Brian G Reid; Jerome Schaack; Carol A Sartorius; Daniel V LaBarbera
Journal:  J Biomol Screen       Date:  2012-06-29

6.  The requirement for p42/p44 MAPK activity in progesterone receptor-mediated gene regulation is target gene-specific.

Authors:  Lindsey S Treviño; William E Bingman; Dean P Edwards; Weigel Nl
Journal:  Steroids       Date:  2013-02-01       Impact factor: 2.668

7.  In pulmonary lymphangioleiomyomatosis expression of progesterone receptor is frequently higher than that of estrogen receptor.

Authors:  Ling Gao; Michael M Yue; Jennifer Davis; Elisabeth Hyjek; Lucia Schuger
Journal:  Virchows Arch       Date:  2014-02-26       Impact factor: 4.064

8.  Progesterone-inducible cytokeratin 5-positive cells in luminal breast cancer exhibit progenitor properties.

Authors:  Sunshine Daddario Axlund; Byong Hoon Yoo; Rachel B Rosen; Jerome Schaack; Peter Kabos; Daniel V Labarbera; Carol A Sartorius
Journal:  Horm Cancer       Date:  2012-11-27       Impact factor: 3.869

9.  Luteolin inhibits progestin-dependent angiogenesis, stem cell-like characteristics, and growth of human breast cancer xenografts.

Authors:  Matthew T Cook; Yayun Liang; Cynthia Besch-Williford; Sandy Goyette; Benford Mafuvadze; Salman M Hyder
Journal:  Springerplus       Date:  2015-08-22

10.  Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferation.

Authors:  Marie Shamseddin; Fabio De Martino; Céline Constantin; Valentina Scabia; Anne-Sophie Lancelot; Csaba Laszlo; Ayyakkannu Ayyannan; Laura Battista; Wassim Raffoul; Marie-Christine Gailloud-Matthieu; Philipp Bucher; Maryse Fiche; Giovanna Ambrosini; George Sflomos; Cathrin Brisken
Journal:  EMBO Mol Med       Date:  2021-05-27       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.